Acute mesenteric arterial occlusion
Executive Summary
Acute mesenteric arterial occlusion is a life-threatening vascular emergency defined by the sudden onset of intestinal hypoperfusion due to the reduction or cessation of arterial blood flow. The superior mesenteric artery (SMA) is most commonly affected, and the condition is primarily caused by two distinct mechanisms: arterial embolism and arterial thrombosis. Clinically, it is characterized by the classic sign of severe abdominal pain that is disproportionately greater than the findings on physical examination.
Diagnosis requires a high degree of clinical suspicion and is most effectively confirmed with high-resolution computed tomography angiography (CTA), which can also help differentiate between embolic and thrombotic etiologies. Management is time-critical, with the primary goals being rapid revascularization of the affected artery and assessment of intestinal viability. Treatment strategies include initial medical stabilization followed by either endovascular intervention or open surgical revascularization, with the choice dictated by the patient's clinical stability and the underlying cause.
Despite advances in diagnosis and treatment, the mortality rate for acute mesenteric arterial occlusion remains high. Prognosis is heavily dependent on the time to diagnosis and intervention. The need for bowel resection due to advanced ischemia or infarction significantly worsens outcomes, with mortality rates exceeding 50% in such cases.
I. Overview and Pathophysiology
Acute mesenteric ischemia refers to the sudden onset of inadequate blood supply to the small intestine. Ischemic injury develops when the delivery of oxygen and nutrients is insufficient to meet the metabolic demands of the intestine, potentially leading to bowel infarction, sepsis, and death. While this briefing focuses on acute arterial occlusion, other forms include mesenteric venous occlusion and nonocclusive mesenteric ischemia.
Primary Causes: Embolism vs. Thrombosis
Thromboembolic occlusion of the superior mesenteric artery (SMA) is the most common cause, accounting for 67% to 95% of all cases of acute mesenteric ischemia. The two primary mechanisms are:
Mesenteric Arterial Embolism: An embolus (a dislodged thrombus) travels from a remote source and lodges in a mesenteric artery.
Mesenteric Arterial Thrombosis: A thrombus forms directly within a mesenteric artery, typically at a site of preexisting atherosclerotic disease.
An autopsy study noted a ratio of superior mesenteric artery embolus to thrombus of 1.4:1.
Detailed Pathophysiology
Arterial Embolism: Emboli most frequently originate from the left atrium, left ventricle, cardiac valves, or proximal aorta. They tend to lodge at points of natural anatomic narrowing. The large diameter and narrow takeoff angle of the SMA make it particularly susceptible.
Location: Emboli typically lodge 3 to 10 cm distal to the origin of the SMA, which often spares the proximal jejunal branches. Approximately 15% of emboli lodge at the SMA's origin.
Severity: Embolism in the absence of preexisting stenosis causes a more profound reduction in blood flow due to the lack of developed collateral circulation. This effect is exacerbated by concomitant arteriolar vasoconstriction.
Arterial Thrombosis: This typically occurs as an "acute-on-chronic" event, where a thrombus forms on a preexisting atherosclerotic plaque that has progressively narrowed the vessel. The thrombosis often occurs at the origin of the SMA or celiac axis.
Collateral Circulation: Because the underlying atherosclerosis develops over time, patients may have developed significant collateral blood flow. This can sometimes mitigate the severity of the acute event, and some patients may even be asymptomatic until a triggering event (e.g., dehydration, low cardiac output) causes complete occlusion.
II. Etiology and Risk Factors
The risk factors for acute mesenteric arterial occlusion are directly related to the underlying cause of either embolism or thrombosis.
III. Clinical Presentation and Evaluation
Early diagnosis is challenging because initial symptoms and signs are often nonspecific.
Hallmark Symptom: The classic presentation is the acute onset of severe abdominal pain that is strikingly "out of proportion to the physical examination." The abdomen may be soft and non-tender initially, despite the patient reporting excruciating pain.
Associated Symptoms: Bowel emptying (nausea, vomiting, diarrhea) is common in the early stages. The presence of bloody bowel movements suggests more advanced ischemia.
Laboratory Findings: Classic laboratory abnormalities include leukocytosis, metabolic acidosis, and an elevated lactate level. However, these are often signs of advanced ischemia or infarction and may be absent in the early stages of the disease. Normal laboratory findings do not exclude the diagnosis.
Differentiating Clinical Profiles
Embolic Occlusion Profile: The typical patient is older with a known source for embolism, most commonly atrial fibrillation. The onset of pain is sudden and severe. Approximately one-third of these patients have a history of a prior embolic event to another location. An autopsy series found that 68% of patients with mesenteric embolus had a synchronous embolus elsewhere.
Thrombotic Occlusion Profile: The typical patient has a history of atherosclerosis and known peripheral artery disease. They may or may not have an established diagnosis of chronic mesenteric ischemia, which is characterized by postprandial abdominal pain ("intestinal angina"), food fear, and weight loss. However, not all patients with thrombotic occlusion are cachectic; some may be overweight.
IV. Diagnosis
A high level of clinical suspicion in a patient with relevant risk factors is the most critical element for timely diagnosis.
Primary Diagnostic Tool: High-resolution computed tomography angiography (CTA) is the imaging modality of choice for stable patients. It is highly diagnostic for acute mesenteric ischemia and can reliably differentiate between embolic and thrombotic causes.
Diagnostic Imaging Characteristics:
Embolic Occlusion: CTA typically shows an oval-shaped filling defect (thrombus) within a non-calcified arterial segment, often located in the middle or distal portion of the proximal SMA, sparing the first few jejunal branches.
Thrombotic Occlusion: CTA usually reveals a thrombus superimposed on a heavily calcified, occlusive atherosclerotic plaque located at the origin (ostium) of the SMA.
Role of Surgery: For patients who present with signs of peritonitis (e.g., abdominal rigidity, rebound tenderness) or hemodynamic instability, the diagnosis is often made in the operating room. An emergency exploratory laparotomy serves as both a diagnostic and therapeutic procedure.
V. Management Strategies
The overarching goal of management is to restore intestinal blood flow as rapidly as possible to prevent irreversible bowel infarction.
Initial Medical Stabilization
All patients with suspected acute mesenteric ischemia should receive immediate medical support, including:
Bowel Rest: Nothing by mouth (NPO) and nasogastric decompression.
Fluid Resuscitation: To maintain intravascular volume and organ perfusion.
Anticoagulation: Therapeutic anticoagulation with unfractionated heparin to prevent thrombus propagation.
Antibiotics: Empiric broad-spectrum antibiotics to cover for bacterial translocation from the ischemic gut.
Supportive Care: Avoidance of vasopressors that can worsen mesenteric vasoconstriction, administration of a proton pump inhibitor, and supplemental oxygen.
Revascularization: Approaches and Evidence
The choice of revascularization depends on the patient's clinical status, the etiology (embolus vs. thrombus), and local expertise.
Scenario-Based Treatment Approach
Patient with Acute Abdominal Findings (Peritonitis): These patients are not candidates for an initial endovascular approach and require immediate exploratory laparotomy.
For Embolism: The standard treatment is open surgical embolectomy.
For Thrombosis: The preferred treatment is open surgical mesenteric bypass.
Patient with No Acute Abdominal Findings (Hemodynamically Stable): These patients may be candidates for a primary endovascular approach.
For Embolism: Percutaneous aspiration of the clot or catheter-directed thrombolysis are viable alternatives to open surgery.
For Thrombosis: A primary endovascular approach with angioplasty and stenting is a reasonable option, combined with close clinical monitoring.
Bowel Viability and Surgical Strategy
Guiding Principle: The phrase "time is bowel" underscores the urgency of revascularization to prevent infarction.
Intraoperative Assessment: Viability is assessed during surgery. Tools like fluorescein dye or indocyanine green angiography can aid this assessment.
Damage Control Surgery: The recommended approach involves resecting only bowel that is clearly gangrenous or perforated. Bowels of questionable viability should be preserved.
"Second-Look" Laparotomy: A planned re-operation is scheduled for 24 to 72 hours after the initial procedure to re-evaluate the viability of the remaining intestine. It is prudent to "err on the side of bowel preservation" during the initial operation.
VI. Prognosis and Long-Term Management
The prognosis for acute mesenteric arterial occlusion remains poor, with high rates of morbidity and mortality.
Mortality
Mortality remains high, with perioperative rates for open surgical approaches ranging between 31% and 62%.
The need for bowel resection is a critical prognostic factor, associated with a 15-fold increase in mortality, with rates frequently exceeding 50%.
Factors associated with an increased risk of death include: advanced age, chronic kidney disease, diabetes, arrhythmia, hypotension, delay to surgery, and increased lactate.
Complications
Short Bowel Syndrome (SBS): Patients requiring extensive resection of the small bowel are at risk for SBS. Those with less than 100 cm of remaining small bowel typically require lifelong parenteral nutrition.
Long-Term Medical Management
For Embolic Causes: Long-term management is aimed at preventing future embolic events, typically with vitamin K antagonists or novel oral anticoagulants.
For Thrombotic (Atherosclerotic) Causes: Management focuses on cardiovascular risk reduction through antiplatelet therapy and statin therapy.
Surveillance: Following revascularization, patients should undergo periodic surveillance imaging (e.g., duplex ultrasound, CTA) to monitor the patency of the vessel or graft.
